Detalhe da pesquisa
1.
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.
Cancer Immunol Immunother
; 73(3): 45, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349430
2.
A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.
Cytotherapy
; 26(4): 318-324, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340107
3.
Biomarkers for checkpoint inhibition in hematologic malignancies.
Semin Cancer Biol
; 52(Pt 2): 198-206, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29775689
4.
The role of surface molecule CD229 in Multiple Myeloma.
Clin Immunol
; 204: 69-73, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30326256
5.
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.
Blood
; 140(2): 152-156, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537186
6.
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells.
Haematologica
; 109(2): 682-688, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37675514
7.
Bypassing the cytokine sink: IL-2-independent IL-2 receptor signaling.
Mol Ther
; 31(8): 2304-2306, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482059
8.
Current Strategies for the Immunotherapy of Multiple Myeloma.
Oncology (Williston Park)
; 31(1): 55-63, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28090624
9.
Chimeric Antigen Receptor (CAR) therapy for multiple myeloma.
Br J Haematol
; 172(5): 685-98, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26791002
10.
Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma.
Br J Haematol
; 171(5): 752-62, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26456863
11.
Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma.
J Transl Med
; 13: 197, 2015 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26088750
12.
Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
Int J Cancer
; 135(5): 1142-52, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24482145
13.
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation.
Cancer Immunol Immunother
; 63(11): 1151-62, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25078248
14.
5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity.
Mediators Inflamm
; 2014: 418292, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24757283
15.
Restricting CAR T Cell Trafficking Expands Targetable Antigen Space.
bioRxiv
; 2024 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370665
16.
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity.
Sci Transl Med
; 15(705): eadd7900, 2023 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467316
17.
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).
Hum Vaccin Immunother
; 19(2): 2216116, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37278257
18.
Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.
Clin Dev Immunol
; 2012: 134081, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22481961
19.
Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity.
Trends Biotechnol
; 40(7): 875-890, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078657
20.
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine.
J Immunother Cancer
; 10(7)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35851312